In lung cancer, the G12D mutation tends to trigger immune escape by modulating the downstream PI3K/AKT pathway and diminishing the activation of the HMGA2-CXCL10/11 signaling pathway, thereby reducing the expression of PD-L1 and the infiltration of tumor-infiltrating lymphocytes (TILs) [48]. This evidence concerns the gene CD274 and neoplasm.